BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND PCSK7, Q16549, 9159, ENSG00000160613, PC8, SPC7, PC7, LPC
79 results:

  • 1. [Influence factors of erectile dysfunction in patients with localized prostate cancer after radical surgery].
    Wang SH; Shi XQ; Ma MF; Jin XX; Zhao XD; Zhou YL; Gu YF; Hu J; Dong N; Dong J; Xu S
    Zhonghua Nan Ke Xue; 2023 Dec; 29(12):992-999. PubMed ID: 38639951
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Spatial MS multiomics on clinical prostate cancer tissues.
    Truong JXM; Rao SR; Ryan FJ; Lynn DJ; Snel MF; Butler LM; Trim PJ
    Anal Bioanal Chem; 2024 Mar; 416(7):1745-1757. PubMed ID: 38324070
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients.
    Freedland SJ; Nair S; Lin X; Karsh L; Pieczonka C; Potluri R; Brookman-May SD; Mundle SD; Fleming S; Agarwal N
    World J Urol; 2023 Dec; 41(12):3535-3542. PubMed ID: 37966506
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Lipidomics and pancreatic cancer risk in two prospective studies.
    Naudin S; Sampson JN; Moore SC; Albanes D; Freedman ND; Weinstein SJ; Stolzenberg-Solomon R
    Eur J Epidemiol; 2023 Jul; 38(7):783-793. PubMed ID: 37169992
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Physicochemical and Biopharmaceutical Controllability of New Self-Assembled Fatty Acid Conjugated Leuprolide for the Enhanced Anticancer Activity.
    Ngo HV; Bak HE; Nguyen HD; Lee KW; Park C; Lee BJ
    Int J Nanomedicine; 2023; 18():2325-2344. PubMed ID: 37168738
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Choosing active surveillance versus curative treatment in a population-based survey of men with low-risk prostate cancer.
    Xu J; Janisse J; Goodman M
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696653
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Examining the effectiveness and implementation of patient treatment decision-aid tools for men with localised prostate cancer: A systematic review.
    Todio E; Sharp J; Morrow A; Taylor N; Schofield P; Mazariego C
    Psychooncology; 2023 Apr; 32(4):469-491. PubMed ID: 36610001
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Coadministration of Apalutamide and Relugolix in Patients with Localized prostate cancer at High Risk for Metastases.
    Brown G; Belkoff L; Hafron JM; Saltzstein DR; Potdar R; Bhaumik A; Phillips J; McGowan T; Shore ND
    Target Oncol; 2023 Jan; 18(1):95-103. PubMed ID: 36472728
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Epigenome-wide DNA methylation and transcriptome profiling of localized and locally advanced prostate cancer: Uncovering new molecular markers.
    Liu Q; Reed M; Zhu H; Cheng Y; Almeida J; Fruhbeck G; Ribeiro R; Hu P
    Genomics; 2022 Sep; 114(5):110474. PubMed ID: 36057424
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions.
    Pozzar RA; Xiong N; Hong F; Filson CP; Chang P; Halpenny B; Berry DL
    BMC Med Inform Decis Mak; 2022 Aug; 22(1):223. PubMed ID: 36002847
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Extraction of Treatment Information From Electronic Health Records and Evaluation of Testosterone Recovery in Patients With prostate cancer.
    Guin S; Jun T; Patel VG; Ayers KL; Deitz M; Cai Y; Zhou X; Tsao CK; Oh WK; Chen R; Liaw BC
    JCO Clin Cancer Inform; 2022 Jun; 6():e2200010. PubMed ID: 35696627
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Decisional Conflict is Associated with Treatment Modality and not Disease Knowledge in South African Men with prostate cancer: Baseline Results from a Longitudinal Prospective Observational Study.
    Irusen H; Burger H; Fernandez PW; Van der Merwe A; Esterhuizen T; du Plessis DE; Seedat S
    Cancer Control; 2022; 29():10732748221082791. PubMed ID: 35442835
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Plasma lipidomic profiles of kidney, breast and prostate cancer patients differ from healthy controls.
    Wolrab D; Jirásko R; Peterka O; Idkowiak J; Chocholoušková M; Vaňková Z; Hořejší K; Brabcová I; Vrána D; Študentová H; Melichar B; Holčapek M
    Sci Rep; 2021 Oct; 11(1):20322. PubMed ID: 34645896
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hybrid Tomo-Helical and Tomo-Direct radiotherapy for localized prostate cancer.
    Karaca S; Koca T; Sarpün İH; Tunçel N; Korcum Şahin AF
    J Appl Clin Med Phys; 2021 Oct; 22(10):136-143. PubMed ID: 34498363
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. High level of phosphatidylcholines/lysophosphatidylcholine ratio in urine is associated with prostate cancer.
    Li X; Nakayama K; Goto T; Kimura H; Akamatsu S; Hayashi Y; Fujita K; Kobayashi T; Shimizu K; Nonomura N; Ogawa O; Inoue T
    Cancer Sci; 2021 Oct; 112(10):4292-4302. PubMed ID: 34328656
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Low conflict and high satisfaction: Decisional outcomes after attending a combined clinic to choose between robotic prostatectomy and radiotherapy for prostate cancer.
    Smith A'; Rincones O; Mancuso P; Sidhom M; Wong K; Berry M; Forstner D; Ngo D; Bokey L; Girgis A
    Urol Oncol; 2022 Jan; 40(1):8.e1-8.e9. PubMed ID: 34116935
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The effectiveness of psychological intervention for depression, anxiety, and distress in prostate cancer: a systematic review of literature.
    Mundle R; Afenya E; Agarwal N
    Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):674-687. PubMed ID: 33750905
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Liproca Depot: A New Antiandrogen Treatment for Active Surveillance Patients.
    Klotz L; Grudén S; Axén N; Gauffin C; Wassberg C; Bjartell A; Giddens J; Incze P; Jansz K; Jievaltas M; Rendon R; Richard PO; Ulys A; Tammela TL
    Eur Urol Focus; 2022 Jan; 8(1):112-120. PubMed ID: 33583762
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Pathology grade influences competing mortality risks in elderly men with prostate cancer.
    Alam MU; Kumar J; Norez D; Tanneru K; Jazayeri SB; Bazargani S; Costa J; Bandyk M; Ganapathi HP; Koochekpour S; Gautam S; Balaji KC
    Urol Oncol; 2021 Aug; 39(8):493.e1-493.e7. PubMed ID: 33353870
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Heart transplantation in patients with localized prostate cancer-Are we denying a life-saving therapy due to an indolent tumor?
    Raikhelkar J; Pham M; Lourenco L; Narang N; Chung B; Nguyen A; Kim G; Sayer G; Uriel N
    Clin Transplant; 2020 Nov; 34(11):e14080. PubMed ID: 32941663
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.